Leading the Way in Life Science Technologies

GEN Exclusives

More »

March 1, Vol. 33, No. 5

  • Columns

    • Zapping Pathological Proteins in Alzheimer’s
    • Carol Potera
    • AC Immune is fighting Alzheimer’s disease on three fronts armed with monoclonal antibodies, vaccines, and small molecules It is attacking amyloid beta (Abeta) oligomers and tau tangles, the key misfolded proteins involved in the pathological processes of Alzheimer’s... more »
    • Rise of Cell-Based Immunotherapy
    • Lee Buckler, J.D.
      Enal Razvi
    • There is much excitement in the growth and evolution of the personalized medicine field driven in large part by the approvals of 15 companion diagnostics-therapeutics combinations primarily addressing various classes of cancer However, the field of personalized medicine is broader ... more »
    • Small Firms Look Optimistically to Future
    • Gail Dutton
    • While many large-cap biotech companies that presented during this year’s “JP Morgan Healthcare” conference are retrenching and repurchasing stock, the small and medium cap biotechs are looking forward optimistically Innovative firms are anticipating late-stage clinical trial results and, generally, good ... more »
    • People in the News
    • Cytovance Biologics added Maria Lopez as vp of quality Prior to Cytovance, she served as the site quality head at Novartis Before Novartis, Lopez held the position of director of quality and manager of quality assurance at Immucor Prior to ... more »